Neuroimmunological Aberrations and Cerebral Asymmetry Abnormalities in Schizophrenia: Select Perspectives on Pathogenesis

키워드

참고문헌 (124)

1. van Os J, "Schizophrenia", Lancet, 374, pp.635~645 (2009)
2. Keshavan MS, "Schizophrenia, "just the facts": what we know in 2008 Part 3: neurobiology", Schizophr Res, 106, pp.89~107 (2008)
3. Rapoport JL, "The neurodevelopmental model of schizophrenia: update 2005", Mol Psychiatry, pp.434~449 (2005)
4. Nicodemus KK, "Serious obstetric complications interact with hypoxia-regulated", vascular-expression genes to influence schizophrenia risk, 2008, pp.13, 873~877
5. Brown AS, "Prenatal infection and schizophrenia:a review of epidemiologic and translational studies", Am J Psychiatry, 167, pp.261~280 (2010)
6. Brown AS., "Exposure to prenatal infection and risk of schizophrenia", Front Psychiatry, 2, pp.63~ (2011)
7. Madhusudan A, "Impact of prenatal immune system disturbances on brain development", J Neuroimmune Pharmacol, 8, pp.79~86 (2013)
8. Garay PA, "Novel roles for immune molecules in neural development: implications for neurodevelopmental disorders", Front Synaptic Neurosci, 2, pp.136~ (2010)
9. Geschwind N, "Cerebral lateralization. Biological mechanisms, associations, and pathology: III. A hypothesis and a program for research", Arch Neurol, 42, pp.634~654 (1985)
10. Geschwind N, "Cerebral lateralization. Biological mechanisms, associations, and pathology: II. A hypothesis and a program for research", Arch Neurol, 42, pp.521~552 (1985)
11. Geschwind N, "Cerebral lateralization. Biological mechanisms, associations, and pathology: I. A hypothesis and a program for research", Arch Neurol, 42, pp.428~459 (1985)
12. Stoyanov Z, "Season of birth, Geschwind and Galaburda hypothesis, and handedness", Laterality, 16, pp.607~619 (2011)
13. Stoyanov Z, "Brain asymmetry, immunity, handedness", Cent Eur J Med, 7, pp.1~8 (2012)
14. Tochigi M, "What causes seasonality of birth in schizophrenia?", Neurosci Res, 48, pp.1~11 (2004)
15. Patterson PH., "Neuroscience. Maternal effects on schizophrenia risk", Science, 318, pp.576~577 (2007)
16. Smith SE, "Maternal immune activation alters fetal brain development through interleukin-6", J Neurosci, 27, pp.10695~10702 (2007)
17. Brown AS., "Prenatal infection as a risk factor for schizophrenia", Schizophr Bull, 32, pp.200~202 (2006)
18. Eyles D, "Schizophrenia: do all roads lead to dopamine or is this where they start? Evidence from two epidemiologically informed developmental rodent models", Transl Psychiatry, 2, pp.e81~ (2012)
19. Ashdown H, "The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia", Mol Psychiatry, 11, pp.47~55 (2006)
20. Beloosesky R, "Maternal N-acetylcysteine suppresses fetal inflammatory cytokine responses to maternal lipopolysaccharide", Am J Obstet Gynecol, 195, pp.1053~1057 (2006)
21. Meyer U, "Prenatal and postnatal maternal contributions in the infection model of schizophrenia", Exp Brain Res, 173, pp.243~257 (2006)
22. Dugan LL, "IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase", PLoS One, 4, pp.e5518~ (2009)
23. Samuelsson AM, "Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA", GABA(A)dysregulation and impaired spatial learning, 2006, pp.290, R1345~R1356
24. Carpenter LL, "Association between plasma IL-6 response to acute stress and early-life adversity in healthy adults", Neuropsychopharmacology, 35, pp.2617~2623 (2010)
25. Sasayama D, "Increased cerebrospinal fluid interleukin-6levels in patients with schizophrenia and those with major depressive disorder", J Psychiatr Res, 47, pp.401~406 (2013)
26. Potvin S, "Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review", Biol Psychiatry, 63, pp.801~808 (2008)
27. Paul-Samojedny M, "Functional polymorphism in the interleukin-6 and interleukin-10 genes in patients with paranoid schizophrenia-a case-control study", J Mol Neurosci, 42, pp.112~119 (2010)
28. Marsland AL, "Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults", Biol Psychiatry, 64, pp.484~490 (2008)
29. Behrens MM, "Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia", J Neurosci, 28, pp.13957~13966 (2008)
30. Bauer S, "The neuropoietic cytokine family in development, plasticity, disease and injury", Nat Rev Neurosci, 8, pp.221~232 (2007)
31. Sargent IL, "Immunoregulation in normal pregnancy and pre-eclampsia: an overview", Reprod Biomed Online, 13, pp.680~686 (2006)
32. Sargent IL, "NK cells and human pregnancy--an inflammatory view", Trends Immunol, 27, pp.399~404 (2006)
33. Zimmerman AW, "Maternal antibrain antibodies in autism", Brain Behav Immun, 21, pp.351~357 (2007)
34. Sparkman NL, "Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers", J Neurosci, 26, pp.10709~10716 (2006)
35. Murphy PG, "Reciprocal actions of interleukin-6 and brain-derived neurotrophic factor on rat and mouse primary sensory neurons", Eur J Neurosci, 12, pp.1891~1899 (2000)
36. Buckley PF, "Brain-derived neurotrophic factor: findings in schizophrenia", Curr Opin Psychiatry, 24, pp.122~127 (2011)
37. Favalli G, "The role of BDNF in the pathophysiology and treatment of schizophrenia", J Psychiatr Res, 46, pp.1~11 (2012)
38. Pezawas L, "The brain-derived neurotrophic factor val66met polymorphism and variation in human cortical morphology", J Neurosci, 24, pp.10099~10102 (2004)
39. Shoval G, "The possible role of neurotrophins in the pathogenesis and therapy of schizophrenia", Eur Neuropsychopharmacol, 15, pp.319~329 (2005)
40. Meyer U, "A review of the fetal brain cytokine imbalance hypothesis of schizophrenia", Schizophr Bull, 35, pp.959~972 (2009)
41. Venkatasubramanian G, "Insulin and insulin-like growth factor-1 abnormalities in antipsychoticnaive schizophrenia", Am J Psychiatry, 164, pp.1557~1560 (2007)
42. Doré S, "Insulin-like growth factor I protects and rescues hippocampal neurons against betaamyloid-and human amylin-induced toxicity", Proc Natl Acad Sci U S A, 94, pp.4772~4777 (1997)
43. de Martino M, "Interleukin-6 release by cultured peripheral blood mononuclear cells inversely correlates with height velocity, bone age, insulin-like growth factor-I, and insulinlike growth factor binding protein-3 serum levels in children with perinatal HIV-1 infection", Clin Immunol, 94, pp.212~218 (2000)
44. Hsiao EY, "Activation of the maternal immune system induces endocrine changes in the placenta via IL-6", Brain Behav Immun, 25, pp.604~615 (2011)
45. Harrison PJ., "The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications", Psychopharmacology (Berl), 174, pp.151~162 (2004)
46. Heckers S., "The hippocampus in schizophrenia", Am J Psychiatry, 161, pp.2138~2139 (2004)
47. Tamminga CA, "The hippocampal formation in schizophrenia", Am J Psychiatry, 167, pp.1178~1193 (2010)
48. 이유진, "Adult hippocampal neurogenesis and related neurotrophic factors", BMB reports, 42(5), pp.239~244 (2009), 한국생화학분자생물학회
49. Fishman D, "The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis", J Clin Invest, 102, pp.1369~1376 (1998)
50. Broca P., "Rapport sur un memoire de M. Armand de Fleury intitulé: De l'inegalité dynamique des deux hemisphères cerébraux", Bull Acad Med, 6, pp.508~539 (1877)
51. Crow TJ., "Cerebral asymmetry and the lateralization of language: core deficits in schizophrenia as pointers to the gene", Curr Opin Psychiatry, 17, pp.97~106 (2004)
52. Cantalupo C, "Asymmetric Broca's area in great apes", Nature, 414, pp.505~ (2001)
53. Gannon PJ, "Asymmetry of chimpanzee planum temporale: humanlike pattern of Wernicke's brain language area homolog", Science, 279, pp.220~222 (1998)
54. Glasel H, "A robust cerebral asymmetry in the infant brain: the rightward superior temporal sulcus", Neuroimage, 58, pp.716~723 (2011)
55. Buxhoeveden DP, "Lateralization of minicolumns in human planum temporale is absent in nonhuman primate cortex", Brain Behav Evol, 57, pp.349~358 (2001)
56. Moore JK, "Cytoarchitectural and axonal maturation in human auditory cortex", J Assoc Res Otolaryngol, 2, pp.297~311 (2001)
57. Chance SA, "Minicolumn thinning in temporal lobe association cortex but not primary auditory cortex in normal human ageing", Acta Neuropathol, 111, pp.459~464 (2006)
58. Shenton ME, "A review of MRI findings in schizophrenia", Schizophr Res, 49, pp.1~52 (2001)
59. Chance SA, "Auditory cortex asymmetry, altered minicolumn spacing and absence of ageing effects in schizophrenia", Brain, 131, pp.3178~3192 (2008)
60. Satz P, "Atypical handedness in schizophrenia:some methodological and theoretical issues", Schizophr Bull, 25, pp.63~78 (1999)
61. Sommer I, "Handedness, language lateralisation and anatomical asymmetry in schizophrenia: meta-analysis", Br J Psychiatry, 178, pp.344~351 (2001)
62. Dragovic M, "Handedness in schizophrenia: a quantitative review of evidence", Acta Psychiatr Scand, 111, pp.410~419 (2005)
63. Crow TJ., "Is schizophrenia the price that Homo sapiens pays for language?", Schizophr Res, 28, pp.127~141 (1997)
64. Crow TJ., "The ‘big bang' theory of the origin of psychosis and the faculty of language", Schizophr Res, 102, pp.31~52 (2008)
65. Oertel V, "Reduced laterality as a trait marker of schizophrenia-evidence from structural and functional neuroimaging", J Neurosci, 30, pp.2289~2299 (2010)
66. Geschwind N, "Cerebral lateralization: Biological mechanisms, associations, and pathology" (1987), MIT Press
67. Geschwind N, "Left-handedness: association with immune disease, migraine, and developmental learning disorder", Proc Natl Acad Sci U S A, 79, pp.5097~5100 (1982)
68. Chengappa KN, "Handedness and autoantibodies", Lancet, 338, pp.694~ (1991)
69. Chengappa KN, "The prevalence of autoantibodies among right and left handed schizophrenic patients and control subjects", Biol Psychiatry, 32, pp.803~811 (1992)
70. Chengappa KN, "Left-handed first-episode, neuroleptic-naive schizophrenic patients have a higher prevalence of autoantibodies", Schizophr Res, 8, pp.75~80 (1992)
71. Hassler M., "Anomalous dominance, immune parameters, and spatial ability", Int J Neurosci, 68, pp.145~156 (1993)
72. Hassler M, "Functional brain organization, handedness, and immune vulnerability in musicians and non-musicians", Neuropsychologia, 31, pp.655~660 (1993)
73. Morfit NS, "Handedness and immune function", Brain Cogn, 46, pp.209~213 (2001)
74. Pennington BF, "Left-handedness and immune disorders in familial dyslexics", Arch Neurol, 44, pp.634~639 (1987)
75. Searleman A, "Suspected autoimmune disorders and left-handedness: evidence from individuals with diabetes. Crohn's disease and ulcerative colitis", Neuropsychologia, 25, pp.367~374 (1987)
76. Smith BD, "For better or for worse:left-handedness, pathology, and talent", J Clin Exp Neuropsychol, 11, pp.944~958 (1989)
77. McManus IC, "Geschwind's theory of cerebral lateralization: developing a formal, causal model", Psychol Bull, 110, pp.237~253 (1991)
78. Berenbaum SA, "Evaluating the empirical support for the role of testosterone in the Geschwind-Behan-Galaburda model of cerebral lateralization: commentary on Bryden, McManus, and Bulman-Fleming", Brain Cogn, 27, pp.79~83 (1995)
79. Pennell LM, "Sex affects immunity", J Autoimmun, 38, pp.J282~J291 (2012)
80. Peeva E, "Spotlight on the role of hormonal factors in the emergence of autoreactive B-lymphocytes", Immunol Lett, 101, pp.123~143 (2005)
81. Kang DH, "Frontal brain asymmetry and immune function", Behav Neurosci, 105, pp.860~869 (1991)
82. Neveu PJ., "Asymmetrical brain modulation of the immune response", Brain Res Brain Res Rev, 17, pp.101~107 (1992)
83. Lengen C, "Anomalous brain dominance and the immune system: do left-handers have specific immunological patterns?", Brain Cogn, 69, pp.188~193 (2009)
84. Müller W, "Prenatal androgen exposure modulates cellular and humoral immune function of black-headed gull chicks", Proc Biol Sci, 272, pp.1971~1977 (2005)
85. gene family in schizophrenia: associations and functional implications, "Prog Neuropsychopharmacol Biol Psychiatry", 2013, 49~62
86. Wierzba-Bobrowicz T, "Degeneration of microglial cells in frontal and temporal lobes of chronic schizophrenics", Folia Neuropathol, 42, pp.157~165 (2004)
87. Steiner J, "Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization", Acta Neuropathol, 112, pp.305~316 (2006)
88. Billiards SS, "Development of microglia in the cerebral white matter of the human fetus and infant", J Comp Neurol, 497, pp.199~208 (2006)
89. Barres BA., "The mystery and magic of glia: a perspective on their roles in health and disease", Neuron, 60, pp.430~440 (2008)
90. Giaume C, "Glia: the fulcrum of brain diseases", Cell Death Differ, 14, pp.1324~1335 (2007)
91. Bilbo SD, "Early-life programming of later-life brain and behavior: a critical role for the immune system", Front Behav Neurosci, 3, pp.14~ (2009)
92. Monji A, "Cytokines and schizophrenia:Microglia hypothesis of schizophrenia", Psychiatry Clin Neurosci, 63, pp.257~265 (2009)
93. Miller BJ, "Meta-analysis of cytokine alterations in schizophrenia:clinical status and antipsychotic effects", Biol Psychiatry, 70, pp.663~671 (2011)
94. Doorduin J, "Neuroinflammation in schizophrenia-related psychosis: a PET study", J Nucl Med, 50, pp.1801~1807 (2009)
95. Fujita Y, "Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antibiotic drug minocycline", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.336~339 (2008)
96. Hashimoto K., "Microglial activation in schizophrenia and minocycline treatment", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.1758~1759 (2008)
97. Hashimoto K., "Abnormality of cerebral perfusion in the posterior cingulate gyrus of a refractory patient with schizophrenia and minocycline treatment", Prog Neuropsychopharmacol Biol Psychiatry, 34, pp.1132~ (2010)
98. Chaudhry IB, "Minocycline benefits negative symptoms in early schizophrenia: a randomised double-blind placebocontrolled clinical trial in patients on standard treatment", J Psychopharmacol, 26, pp.1185~1193 (2012)
99. Levkovitz Y, "A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia", J Clin Psychiatry, 71, pp.138~149 (2010)
100. Jhamnani K, "Successful use of add-on minocycline for treatment of persistent negative symptoms in schizophrenia", J Neuropsychiatry Clin Neurosci, 25, pp.E06~E07 (2013)
101. Romero E, "Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia", Mol Psychiatry, 15, pp.372~383 (2010)
102. Borrell J, "Prenatal immune challenge disrupts sensorimotor gating in adult rats. Implications for the etiopathogenesis of schizophrenia", Neuropsychopharmacology, 26, pp.204~215 (2002)
103. Mcghie A, "Disorders of attention and perception in early schizophrenia", Br J Med Psychol, pp.103~116 (1961)
104. Venables PH., "Selectivity of attention, withdrawal, and cortical activation. Studies in chronic schizophrenia", Arch Gen Psychiatry, 9, pp.74~78 (1963)
105. Williams TJ, "Distinct neural generators of sensory gating in schizophrenia", Psychophysiology, 48, pp.470~478 (2011)
106. Patterson JV, "P50 sensory gating ratios in schizophrenics and controls: a review and data analysis", Psychiatry Res, 158, pp.226~247 (2008)
107. Potter D, "Review of clinical correlates of P50 sensory gating abnormalities in patients with schizophrenia", Schizophr Bull, 32, pp.692~700 (2006)
108. Kim SH, "Asymmetry analysis of deformable hippocampal model using the principal component in schizophrenia", Hum Brain Mapp, 25, pp.361~369 (2005)
109. Qiu A, "Neuroanatomical asymmetry patterns in individuals with schizophrenia and their non-psychotic siblings", Neuroimage, 47, pp.1221~1229 (2009)
110. Lang TJ., "Estrogen as an immunomodulator", Clin Immunol, 113, pp.224~230 (2004)
111. Kalaitzidis D, "Transcription factor cross-talk:the estrogen receptor and NF-kappaB", Trends Endocrinol Metab, 16, pp.46~52 (2005)
112. Paimela T, "Influence of selective estrogen receptor modulators on interleukin-6 expression in human retinal pigment epithelial cells (ARPE-19)", Eur J Pharmacol, 640, pp.219~225 (2010)
113. Gingerich S, "Estrogen receptor α and G-protein coupled receptor 30 mediate the neuroprotective effects of 17β-estradiol in novel murine hippocampal cell models", Neuroscience, 170, pp.54~66 (2010)
114. Brann DW, "Neurotrophic and neuroprotective actions of estrogen:basic mechanisms and clinical implications", Steroids, 72, pp.381~405 (2007)
115. Meng JL, "Estrogen protects the dopaminergic neurons in substantia nigra against damage induced by 6-hydroxydopamine", Sheng Li Xue Bao, 60, pp.369~374 (2008)
116. Kulkarni J, "Estrogen in severe mental illness: a potential new treatment approach", Arch Gen Psychiatry, 65, pp.955~960 (2008)
117. Kulkarni J, "Estrogen - a potential treatment for schizophrenia", Schizophr Res, 48, pp.137~144 (2001)
118. Kulkarni J, "Estrogens and men with schizophrenia: is there a case for adjunctive therapy?", Schizophr Res, 125, pp.278~283 (2011)
119. Kulkarni J, "Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia", Psychoneuroendocrinology, 35, pp.1142~1147 (2010)
120. Salvetti NR, "Developmental programming: impact of prenatal testo sterone excess on ovarian cell proliferation and apoptotic factors in sheep", Biol Reprod, 87(22), pp.1~10 (2012)
121. Abi Salloum B, "Developmental programming: prenatal and postnatal contribution of androgens and insulin in the reprogramming of estradiol positive feedback disruptions in prenatal testosterone-treated sheep", Endocrinology, 153, pp.2813~2822 (2012)
122. Kimura D., "Sex, sexual orientation and sex hormones influence human cognitive function", Curr Opin Neurobiol, 6, pp.259~263 (1996)
123. Sanders G, "Verbal and music dichotic listening tasks reveal variations in functional cerebral asymmetry across the menstrual cycle that are phase and task dependent", Neuropsychologia, 36, pp.869~874 (1998)
124. Doty RL, "Estrogen replacement therapy induces functional asymmetry on an odor memory", discrimination test, 2008, pp.1214, 35~39

관련 논문AI추천